The Hematologic Malignancy Center at Dana-Farber/Boston Children's Cancer and Blood Disorders Center is one of the top centers of it's kind in the world. In addition to treating lymphomas and leukemias, we treat the primary types of histiocytosis, which is not a form of cancer but shares some common characteristics and is often treated using some of the same therapies.
Highlights of the Hematologic Malignancy Center include:
A specialized program for patients receiving cancer treatment who have experienced a decrease or loss of reproductive function.
Providing care and advocacy for survivors of childhood cancer through ongoing education, support and research on the long-term effects of cancer treatments.
Social workers, psychologists and resource specialists offering help with the social, emotional, and psychological aspects of caring for children with cancer.
Sarah Levin is 11 years old, and has beaten acute lymphoblastic leukemia (ALL) twice. This is her story in her own words on the Boston Children's Hospital Blog Thriving.
As a teaching affiliate of Harvard Medical School, our physicians are passing on their expertise to the next generation of pediatric hematologists and oncologists.